Protons lose their energy to matter primarily through electromagnetic interactions with atomic electrons. Protons have a mass which is large compared to the mass of the electrons, hence they lose only a small fraction of their energy in a single interaction (at most 4 m 1M 0.0022, where m is the
electron mass and M is the proton mass) and they are deflected by only small angles in each interaction. In general, the proton interactions with matter can be divided into three categories (Bichsel, 1968) : interactions with the individual electrons of atoms, interactions with the nucleus and interactions with the atoms as a whole. The latter occur only at very low and will not be considered in this Report. Nuclear interactions include inelastic scattering, Rutherford scattering and nuclear reactions. Although this document will consider the effects of nuclear interactions on dosimetry, it will concentrate mostly on the description of proton interactions with electrons of atoms and molecules, since at therapy energies, these processes dominate.
The primary dosimetric quantity of interest for radiotherapy is the absorbed dose, which is defined as the mean energy imparted per unit mass of material (see Equation 3.15). For charged particles, the fundamental energy loss quantity is cema (Equation 3.14) although, as discussed in Section 3.4 above, it is reasonable to assume that absorbed dose is numerically equal to cema. The processes by which protons slow down and deposit energy along their tracks determine the distribution of absorbed dose in the patient.
In the slowing down of protons in any material, some of the molecules ofthe material are excited, but the more important effect is ionization. If the kinetic energy imparted to an electron in the ionization process is sufficient for it, in turn, to cause subsequent ionization, it is called a 15 ray. The average energy required to produce an ion pair, referred to as W, is an important dosimetric quantity, particularly for ionization chambers. Section 5 of this Report will deal with Win more detail.
Application of the ionization phenomenon can be seen in the use of semiconductors or gases as particle detectors. When charged particles lose energy in a semiconductor, electrons are excited from the valence band to the conduction band, thereby changing the conduction properties of the material. With the application of an applied potential, current flow can be used as a measure of the energy deposited by charged particles. The operation of ionization chambers also depends on current measurement. Ionizations and excitations in photographic emulsions can form a permanent record of the passage of charged particles following the development process. In some materials (scintillators), ionizations and excitations can produce light quanta in the visible range.
Energy Deposition

Average Energy Loss
The proton mass stopping power of a medium, (SIp), is defined in Equation 3.11. Frequently, the unit MeV cm 2 g-l is used, where the areal density (in g cm-2 ) is defined as the product of density p and absorber thickness t. In the continuous-slowing-down approximation (csda), the range of a particle is given
Due to the fact that each particle experiences a different set of interactions, a group of particles ofthe same initial energy has a distribution of energies after traversing a thickness of absorber (energy straggling) and a resulting distribution of depths at which the particles stop (range straggling).
Radiation dosimetry and radiobiological modeling are concerned with the deposition of energy along the track of single charged particles. This is specified by the restricted stopping power or LET (linear energy transfer), (Equation 3.12), defined as the mean energy loss per unit pathlength due to collisions involving energy transfers that are smaller than some cutoff. This cutoff is chosen to correspond to the energy of secondary electrons with ranges which are equal to a relevant radius around the particle track. This restricted stopping power specifies an average energy loss and is a non-stochastic quantity. Actual energy deposition is specified by the stochastic quantities of micro dosimetry.
Proton energy loss mechanisms may be considered in three separate proton energy regions: Low energy, below 10-5 Mc 2 (where Mc 2 refers to the particle's rest mass), intermediate energy, and high energy, above Mc 2 • In each of these energy regions, qualitatively different energy loss phenomena dominate.
At low energies, which for protons is below about 0.01 MeV, elastic collisions between the particles and whole atoms of the medium are important. Since this region corresponds to less than one /Lm of the proton trajectory in tissue, it can be ignored for purposes of proton dosimetry for radiotherapy.
At increasing energy, the nuclear interactions become more important. In the intermediate energy range, the probability of nuclear events is small compared to the probability of electron interactions, although each nuclear reaction can transfer a significant portion of the proton energy to the medium. For very high energy protons of 1,000 MeV and above, the probability of suffering a nuclear interaction before the end of the range (as defined by electron interactions) is high, hence the entire concept of range becomes less meaningful. In addition, proton bremsstrahlung begins to contribute to the energy loss and bulk properties of the medium (dielectric constant, etc.) begin to influence the collision process and modify the stopping power via the phenomenon called the density or polarization effect (Sternheimer, 1966) .
In the energy range between 0.01 MeV and 250 MeV, where the residual range of the protons in tissue is between a micron and approximately 35 cm, interactions with electrons are dominant. Even at these energies, however, one cannot ignore the effects of nuclear interactions. For tissue-equivalent material, the probability that protons will undergo a nuclear interaction while traversing a path length segment of 1 g cm-2 is of the order of 1 % (ICRU, 1993) . At a depth of 20 cm, approximately 1 in 4 of the protons will have suffered a nuclear interaction. This will contribute a background of nuclear interaction products (Kliauga et al., 1978) which can modify the biological effect of the proton radiation (Hall et al., 1978; Verhey et al., 1979) . Nuclear interactions affect the identity and energy distribution of the secondary particles and decrease the number of primary protons in the beam.
The mass electronic stopping power of matter for protons, calculated purely on the basis of electronic interactions (lCRU, 1993) , is given by:
where ze and ~ refer to the charge and the speed (in units of c, the velocity oflight) of the incident proton, m is the mass of the electron, Z, N and I refer to the mean nuclear charge, the mean density and the mean excitation energy of the atoms of the medium and C/ Z represents the shell corrections which are most important at low velocities (Bichsel, 1968; Bichsel, 1992) . For protons of very high energy (with f3 > 0.9), an additional term needs to be added to the stopping power equation which corrects for the density effect (Sternheimer, 1966) . ICRU Report 49 (lCRU, 1993) tabulates proton stopping powers in the entire energy range of interest for radiotherapy.
Microdosimetric Concepts
Although the average energy loss per unit mass, the absorbed dose, is a useful macroscopic concept defining the ambient energy concentration at the site of interest, the microscopic local energy density or specific energy z = elm as defined in Equation
3
.19, may reach far higher values for very small volumes. The specific energy in microscopic domains is responsible for biological and chemical radiation effects which are generally produced more efficiently by high-LET rather than low-LET radiations. At the energies employed in therapy, protons can be regarded as low-LET radiation. However, a small portion of the energy loss of protons is through nuclear interactions, leading to a small probability of large local depositions of energy. Measurements of the dose-weighted lineal energy distribution (see Equation 3.18) in a clinical proton beam indicate that not more than about 2% of the absorbed dose is due to these types of events (Kliauga et al., 1978) for energies less than 250 Me V but, because of their high biological effectiveness, their contribution is not negligible. This subject will be considered in Part II of this Report.
Factors which Affect Proton Beam Characteristics
The interactions of protons with matter can be described statistically since they are made up of a very large number of events, each of which is responsible for only a small amount of energy loss (average energy losses per collision are of the order of 100 eV). Nuclear events result in the loss of the primary protons and the production of secondary particles. For a monoenergetic parallel beam of protons striking matter, one will observe (Bichsel and Hiraoka, 1989):
1. the production of secondary electrons (8 rays) from ionizations, 2. the loss of primary protons before the end of range due to nuclear interactions and the resulting creation of secondary particles, as well as the following phenomena, all of which depend on both the thickness of material traversed and the incident energy, namely, 3. range straggling, i.e., a distribution of stopping depths around a mean which can be calculated and which has a width that depends on the material of the absorber, 4. energy straggling, i.e., a distribution of energies around a mean value which can be determined in an energy loss calculation, and 5. an angular distribution around the central axis with a width which can be calculated from multiple scattering theory (Bethe, 1953; Bichsel et al., 1982) . Although proton stopping power can be calculated at any given energy, the presence of nuclear events and the difficulty of measuring the beam characteristics lead one to conclude that absorbed dose in the patient and clinical proton beam parameters should be based on measurements made in materials as similar as possible to the patient. Section 7 of this Report recommends dosimetry procedures which should be used to calculate absorbed dose in the patient.
